Drug
MZ 1866
MZ 1866: highest development phase Phase 1/2, developed by Mahzi Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Mahzi Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| MZ-1866 NCT07135050 | Phase 1/2 | Pitt Hopkins Syndrome |
Latest
No recent events.
Follow MZ 1866 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.